当前位置:主页 > 医学论文 > 肿瘤论文 >

常用肿瘤标志物在上皮性卵巢癌诊断中的临床价值

发布时间:2018-06-01 02:23

  本文选题:肿瘤标志物 + 联合检测 ; 参考:《中国现代医学杂志》2017年15期


【摘要】:目的研究常用肿瘤标志物糖链抗原(CA125和CA199)、人附睾蛋白4(HE4)、乳酸脱氢酶(LDH)单项及联合检测在上皮性卵巢癌诊断中的临床价值。方法用化学发光微粒子免疫检测法和酶速率法检测220例上皮性卵巢癌患者、78例卵巢上皮性交界性肿瘤患者、120例卵巢成熟性畸胎瘤患者及162例卵巢子宫内膜异位症患者血清中肿瘤标志物浓度。结果 (1)上皮性卵巢癌组的CA125、CA199、HE4及LDH高于其他3组(P0.008);(2)4种肿瘤标志物中HE4诊断上皮性卵巢癌的敏感性为73.18%,特异性为98.89%,约登指数(Youden index)为72.07%,受试者工作特征曲线(ROC曲线)下面积为0.952,综合其他评价指标,可得出HE4的诊断能力最好;(3)联合检测组中CA125、CA199、HE4及LDH四项联合检测诊断上皮性卵巢癌的敏感性为97.73%,特异性为25.00%,ROC曲线下面积为0.973,其诊断价值最高。结论 CA125、CA199、HE4及LDH 4项联合检测是诊断上皮性卵巢癌比较理想的肿瘤标志物组合,对卵巢良恶性肿瘤的鉴别诊断具有重要临床价值。
[Abstract]:Objective to study the clinical value of single and combined detection of carbohydrate chain antigen CA125 and CA199, human epididymal protein 4H4, lactate dehydrogenase (LDH) in the diagnosis of epithelial ovarian cancer. Methods the chemiluminescence microparticle immunoassay and enzyme rate assay were used to detect 220 cases of epithelial ovarian cancer and 78 cases of ovarian epithelial sexual intercourse borderline tumor. 120 cases of ovarian mature teratoma and 162 cases of ovarian endometriosis were detected. Serum tumor markers in patients. Results (1) the sensitivity of HE4 in diagnosis of epithelial ovarian cancer was 73.18, the specificity was 98.89 and the Jordan index (Youden index) was 72.07. The sensitivity of HE4 in diagnosing epithelial ovarian cancer was 73.18, the Youden index was 72.07, and the operating characteristic curve (ROC) was higher than that in the other three groups (P 0.008). The area under it is 0.952. It can be concluded that the diagnostic ability of HE4 is the best. In the combined detection group, the sensitivity of CA125, CA199HE4 and LDH in the diagnosis of epithelial ovarian cancer is 97.73 and the specificity is 25.00. The area under the ROC curve is 0.973.The diagnostic value is the highest. Conclusion the combined detection of CA125, CA199HE4 and LDH is an ideal combination of tumor markers for the diagnosis of epithelial ovarian cancer, and has important clinical value in the differential diagnosis of benign and malignant ovarian tumors.
【作者单位】: 新疆医科大学附属肿瘤医院;
【分类号】:R737.31

【参考文献】

相关期刊论文 前10条

1 岳娟;刘菲;李艳红;;卵巢癌早期诊断的血清肿瘤标记物研究进展[J];国际妇产科学杂志;2015年05期

2 侯娟娟;虎淑妍;刘婷婷;张玲;席维岳;郑红军;潘云燕;;血清肿瘤标志物在卵巢癌早期诊断中的临床价值[J];中国免疫学杂志;2014年08期

3 武春梅;李霞莲;李玲;尹莉莉;李倩;;联合检测肿瘤标志物在卵巢肿瘤诊断中的应用[J];国际检验医学杂志;2014年06期

4 李洪英;王兰;;子宫内膜异位症不孕患者血清CA125水平与术后妊娠结局的关系[J];河北医学;2014年02期

5 张月萍;;人附睾蛋白4诊断卵巢癌的临床应用[J];中国实验诊断学;2013年01期

6 沈立松;周韵斓;尚红;潘柏申;;肿瘤标志物的临床应用建议[J];中华检验医学杂志;2012年02期

7 辛亚兰;王卡娜;何荣霞;;血清肿瘤标志物在上皮性卵巢癌早期诊断中研究进展[J];中国妇幼保健;2011年10期

8 范文勇;;血浆CA125在不同妇科疾病中的表达水平及其对疗效的评估价值[J];中国当代医药;2011年03期

9 朱亚林;霍颖;徐永居;;血清AFP、CEA、CA19-9、CA125、TSGF联检对卵巢癌的诊断价值[J];放射免疫学杂志;2009年04期

10 秦万平;林R,

本文编号:1962495


资料下载
论文发表

本文链接:https://www.wllwen.com/yixuelunwen/zlx/1962495.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户95297***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com